SCHEMBL4083104

SCHEMBL4083104

FC(F)(F)c1cccc(Cn2c(Cl)nc3ccccc32)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 5/20 0.54
LMNA P02545 3/20 0.54
MAPT P10636 2/20 0.53
ALDH1A1 P00352 2/20 0.53
ALDH2 P05091 2/20 0.53
ALDH3A1 P30838 2/20 0.53
ALDH1A2 O94788 1/20 0.53
ALDH1A3 P47895 1/20 0.53
POLB P06746 1/20 0.53
CFTR P13569 1/20 0.52
DRD2 P14416 1/20 0.50
MAPK10 P53779 1/20 0.48
KMT2A Q03164 3/20 0.47
MEN1 O00255 2/20 0.47
NPSR1 Q6W5P4 1/20 0.47
TNF P01375 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.46
TSHR P16473 1/20 0.46
HTT P42858 1/20 0.46
PPARG P37231 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31633144 0.82 TSHR (0.66) TP53LMNAMAPTALDH1A1ALDH2
SCHEMBL4083319 0.82 TP53 (0.63) TP53LMNAMAPTALDH1A1ALDH2
SCHEMBL1169953 0.81 LMNA (0.70) TP53LMNAMAPTALDH1A1ALDH2
SCHEMBL4083456 0.81 PPARG (0.47) TP53LMNAMAPTPOLBKMT2A
SCHEMBL27898221 0.79 ALDH1A1 (0.65) TP53LMNAMAPTALDH1A1CFTR
SCHEMBL4083091 0.77 SOS1 (0.57) TP53LMNAMAPTALDH1A1DRD2
SCHEMBL4089473 0.76 MAPT (0.63) TP53LMNAMAPTALDH1A1POLB
SCHEMBL4093174 0.76 CFTR (0.61) TP53LMNAMAPTALDH1A1ALDH2
SCHEMBL29847465 0.76 CFTR (0.77) TP53LMNAMAPTPOLBCFTR
SCHEMBL28591439 0.76 CFTR (0.77) TP53LMNAMAPTPOLBCFTR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090062317-A1 MEDICINAL USE OF RECEPTOR LIGANDS 7TM PHARMA A/S (DK) 2009-03-05 US disclosed
EP-1778670-A2 MEDICINAL USE OF RECEPTOR LIGANDS 7TM Pharma A/S (DK) 2007-05-02 EP disclosed
WO-2006010446-A2 MEDICINAL USE OF RECEPTOR LIGANDS 7TM PHARMA A/S (DK) 2006-02-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090062317-A1 MEDICINAL USE OF RECEPTOR LIGANDS MCHR1, MCHR2, MC1R TP53 4783/4885LMNA 2850/4885MAPT 4135/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.